Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Learn when to select cash back over rewards cards for optimal benefits. Make informed credit choices now!
26,510 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Retirees are increasingly adopting a bucket-style retirement income strategy to cushion withdrawals from market downt...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
Imagine income investments that don’t just pay a dividend, they propel total returns. This article highlights three d...
When a CEO sells stock, investors listen. This article breaks down what the Electronic Arts CEO's roughly $1 million ...
When big defense deals surface, Lockheed Martin stock often reacts. This piece breaks down why lockheed martin stock ...
Two affordable AI stocks could still power meaningful gains over the long run. This guide breaks down SoundHound AI a...
A fresh look at SCHD shows that funding a cash-flow retirement with quarterly dividends still requires several millio...
A sharp rally in tandem diabetes care stock followed a profitability upgrade, signaling a shift from revenue-only gro...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
Alphatec (ATEC) is navigating a shifting spine device market. This guide breaks down expected 2025 earnings, key driv...